-Philip Lazarus Researcher Activity Profile

Research Author Detailed Information 

Philip Lazarus Publication Rate By Year

Philip Lazarus has published 1 paper(s) in 2001, 1 paper(s) in 2004, 13 paper(s) in 2007, 1 paper(s) in 2008, for a total of 16 research publications in total.

Philip P Lazarus Author Information

LAST NAME: lazarus

FIRST NAME: Philip

INITIALS: p

AFFILIATION:

Papers

Philip Lazarus's Publication Record

1. Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants. Year Published: 2007
Cancer Prevention and Control Program, Division of Population Sciences and Cancer Prevention, Department of Pharmacology, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania, USA. dxs76@psu.edu
2. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Year Published: 2007
Gene-Environment Epidemiology Group, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008 Lyon, France. hashibe@iarc.fr
3. Elimination of antiestrogenic effects of active tamoxifen metabolites by glucuronidation. Year Published: 2007
Cancer Prevention and Control, Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
4. Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism. Year Published: 2007
Cancer Prevention and Control Program, Penn State Cancer Institute, Penn State University College of Medicine, Hershey, Pennsylvania 17033, USA.
5. The UGT2B17 gene deletion polymorphism and risk of prostate cancer A case-control study in Caucasians. Year Published: 2007
Departments of Public Health Sciences, Penn State Hershey Medical Center, Hershey, PA 17033, USA.
6. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Year Published: 2007
Cancer Prevention and Control, Penn State Cancer Institute, Department of Pharmacology, Penn State University College of Medicine, Hershey, PA 17033, USA.
7. Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10. Year Published: 2007
Cancer Prevention and Control Program, Penn State Cancer Institute, Penn State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
8. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Year Published: 2007
Departments of Public Health Sciences, Penn State Hershey Medical Center, Hershey, PA 17033, USA.
9. Elimination of antiestrogenic effects of active tamoxifen metabolites by glucuronidation. Year Published: 2007
Cancer Prevention and Control, Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
10. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Year Published: 2007
Cancer Prevention and Control, Penn State Cancer Institute, Department of Pharmacology, Penn State University College of Medicine, Hershey, PA 17033, USA.
11. Metabolic gene polymorphism frequencies in control populations. Year Published: 2001
Environmental and Occupational Health Sciences Institute, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854, USA.
12. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Year Published: 2004
University Maastricht, Maastricht, The Netherlands.
13. Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10. Year Published: 2007
Cancer Prevention and Control Program, Penn State Cancer Institute, Penn State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
14. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Year Published: 2007
Departments of Public Health Sciences, Penn State Hershey Medical Center, Hershey, PA 17033, USA.
15. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Year Published: 2007
Gene-Environment Epidemiology Group, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008 Lyon, France. hashibe@iarc.fr
16. Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines. Year Published: 2008
Cancer Prevention and Control Program, Penn State Cancer Institute, Department of Public Health Sciences, Penn State University College of Medicine, Hershey, Pennsylvania 17033, USA.